pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Panel discusses how questions about health equity shape public trust in science

Sep 18, 2026·read at STAT ↗Neutral

Anil Oza reported that he participated in a National Academies of Science roundtable focused on population health and how research communication influences public trust.

The discussion highlighted that the phrasing used when describing health-equity research can affect how the public perceives science, and that some researchers feel political pressure to stay silent about their findings.

Phillip Alberti of the Association of American Medical Colleges Center for Health Justice cited a poll showing varying support for health-equity policies depending on how questions are asked, underscoring the importance of framing.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Who supports policies for ‘health equity’? It depends on how you’re asking”

read at STAT ↗
1,220 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of HealthUltragenyx Pharmaceutical Inc.
drugs
DisPATCHFENTANYL-37FENTANYL-75fentanylfentanyl CRfentanyl ER
topics
Vaccines3Oncology2NSCLCPulmonologyRare DiseaseRecallType 2 Diabetes

related stories

  • 20h agoSTAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factorSTAT
  • 1d agoPurer fentanyl won’t solve the U.S. overdose death crisis, study saysSTAT
  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT
  • 2d agoU.S. reaches highest number of measles deaths in decadesSTAT
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT